FDA reorganization is crucial to address complexity of products

09/9/2013 | Forbes

The FDA and Commissioner Dr. Margaret Hamburg deserve credit for initiating a task force that will work on plans to change the agency's structure, processes and functions, former FDA official Scott Gottlieb writes. To reflect the increasingly cross-functional complexity of the products that the FDA regulates, the agency is going to need to reorganize its executive units, he writes.

View Full Article in:


Published in Brief: